In the Yaz, Yasmin, and Ocella multicounty litigation (MCL) in the Superior Court of New Jersey in Bergen County, the court filed a new case management order in mid-October. The…
Read More
In Australia, women who claim to have been injured by the contraceptive drugs Yaz and Yasmin, both developed and manufactured by Bayer, are in the beginning stages of filing a…
Read More
The Yaz and Yasmin multidistrict litigation (MDL) convened for a status conference on September 4, 2013 in the U.S. District Court for the Southern District of Illinois. The court met…
Read More
A settlement agreement has been reached between Bayer and plaintiffs who filed a Yaz and Yasmin lawsuit specifically citing gallbladder complications. The settlement agreement between the plaintiffs and Bayer, the…
Read More
According to a Reuters report published on March 4, Bayer allocated $1.5 billion last year as a legal fund for Yaz and Yasmin lawsuits. In anticipation of future settlements of…
Read More
In early November, the U.S. Food and Drug Administration (FDA) released a statement about its recent research into the incidence of excessive bleeding and Pradaxa use in patients with atrial…
Read More
Though the drug manufacturer denies Pradaxa as a defective drug, the surmounting Pradaxa bleeding deaths, injuries, and lawsuits prove otherwise. Pradaxa was introduced onto the U.S. drug market in October…
Read More
On December 19, the U.S. Food and Drug Administration (FDA) released a safety announcement regarding the anticoagulant medicine known as Pradaxa. Pradaxa, known generically as dabigatran etexilate mesylate, is manufactured…
Read More
Transvaginal mesh is used to treat patients with pelvic organ prolapse (POP) and stress urinary incontinence (SUI). As a national law firm representing individuals who believe their injuries (stem) from…
Read More
In a letter from the U.S. Food and Drug Administration (FDA) dated September 19, 2012, Zimmer Holdings Inc. was issued a warning regarding their hip replacement device known as the…
Read More